STIFEL FINANCIAL CORP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$205,000
-2.8%
6,436
+5.3%
0.00%
Q1 2022$211,000
-70.5%
6,113
-75.0%
0.00%
-100.0%
Q4 2021$715,000
+28.1%
24,416
+11.5%
0.00%0.0%
Q3 2021$558,000
+100.7%
21,899
+175.9%
0.00%
Q2 2021$278,000
-20.6%
7,937
-7.6%
0.00%
-100.0%
Q1 2021$350,000
-3.3%
8,588
+2.7%
0.00%0.0%
Q4 2020$362,000
-2.4%
8,361
+24.3%
0.00%0.0%
Q3 2020$371,000
-65.0%
6,728
-59.9%
0.00%
-50.0%
Q2 2020$1,059,000
+35.9%
16,782
+9.6%
0.00%0.0%
Q1 2020$779,000
-43.4%
15,316
-11.8%
0.00%
-33.3%
Q4 2019$1,377,000
+118.9%
17,374
+31.9%
0.00%
+50.0%
Q3 2019$629,000
+1.8%
13,168
+10.9%
0.00%0.0%
Q2 2019$618,000
+3.2%
11,870
+3.7%
0.00%0.0%
Q1 2019$599,000
+36.4%
11,451
+4.0%
0.00%
+100.0%
Q4 2018$439,00011,0120.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders